DEGIACOMI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 1.224
EU - Europa 835
AS - Asia 803
SA - Sud America 148
AF - Africa 15
OC - Oceania 2
Totale 3.027
Nazione #
US - Stati Uniti d'America 1.176
CN - Cina 311
IE - Irlanda 242
SG - Singapore 203
HK - Hong Kong 145
RU - Federazione Russa 145
BR - Brasile 126
DE - Germania 101
IT - Italia 95
FI - Finlandia 78
VN - Vietnam 51
GB - Regno Unito 46
CA - Canada 30
IN - India 27
UA - Ucraina 27
SE - Svezia 19
AT - Austria 15
JP - Giappone 15
MX - Messico 14
BE - Belgio 11
PL - Polonia 11
FR - Francia 10
TR - Turchia 9
NL - Olanda 7
CZ - Repubblica Ceca 6
ES - Italia 6
VE - Venezuela 6
ZA - Sudafrica 6
AR - Argentina 5
BD - Bangladesh 5
IQ - Iraq 5
EC - Ecuador 4
ID - Indonesia 4
IL - Israele 4
KR - Corea 4
AE - Emirati Arabi Uniti 3
CO - Colombia 3
LT - Lituania 3
RO - Romania 3
TW - Taiwan 3
AO - Angola 2
AU - Australia 2
BO - Bolivia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
LV - Lettonia 2
NG - Nigeria 2
PK - Pakistan 2
TH - Thailandia 2
UZ - Uzbekistan 2
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GH - Ghana 1
GM - Gambi 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
MD - Moldavia 1
MY - Malesia 1
NA - Namibia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
TM - Turkmenistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
Totale 3.027
Città #
Dublin 242
Chandler 185
Hong Kong 138
Ashburn 124
Dallas 111
Singapore 101
Beijing 89
Los Angeles 58
Boardman 55
Helsinki 51
Munich 49
Pavia 44
New York 37
Jacksonville 36
Nanjing 36
Lawrence 30
Medford 30
Princeton 30
Shanghai 30
Moscow 27
Ho Chi Minh City 21
Redondo Beach 20
Wilmington 17
Santa Clara 14
The Dalles 14
Turku 14
Tokyo 13
Hanoi 12
Nanchang 12
Vienna 12
Buffalo 11
London 10
Nuremberg 10
São Paulo 10
Changsha 9
Montreal 9
Ottawa 9
Shenyang 9
Warsaw 9
Ann Arbor 8
Hangzhou 8
Phoenix 8
Piscataway 8
Stockholm 8
Brussels 7
Jiaxing 7
San Francisco 7
San Genesio ed Uniti 7
Chennai 6
Chicago 6
Cinisello Balsamo 6
Columbus 6
Falkenstein 6
Hebei 6
Milan 6
Olomouc 6
Boston 5
Charlotte 5
Chongqing 5
Hyderabad 5
Johannesburg 5
New Delhi 5
Tianjin 5
Toronto 5
Washington 5
Birmingham 4
Houston 4
Istanbul 4
Manchester 4
Mexico City 4
Orem 4
Rio de Janeiro 4
San Jose 4
Woodbridge 4
Achel 3
Atlanta 3
Biên Hòa 3
Brasília 3
Brooklyn 3
Curitiba 3
Dearborn 3
Fiorano Modenese 3
Guangzhou 3
Kunming 3
Mumbai 3
Porto Alegre 3
Pune 3
Seattle 3
Sumaré 3
Turin 3
Amsterdam 2
Annapolis 2
Bangkok 2
Baoding 2
Bishkek 2
Calgary 2
Caracas 2
Cleveland 2
Cluj-Napoca 2
Denver 2
Totale 2.003
Nome #
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 138
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 134
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors 123
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals are Uniformly Susceptible to Benzothiazinones 121
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 110
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 106
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 106
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG. 101
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis 96
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 89
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 89
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis 87
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 86
Pyridine-2-thiol 1-oxide derivatives and their use for treatment of mammalian infections caused by Mycobacterium or fungi 81
Nitric oxide-releasing compounds for the treatment of lung infections 75
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 73
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 70
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 68
Age-related changes in PD-1 expression coincide with increased cytotoxic potential in Vδ2 T cells during infancy 68
GarA is an essential regulator of metabolism in mycobacterium tuberculosis 68
The antimalarial mefloquine shows activity against mycobacterium abscessus, inhibiting mycolic acid metabolism 65
Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis 65
Mycobacterium tuberculosis Sulfate Ester Dioxygenase Rv3406 Is Able to Inactivate the RCB18350 Compound. 63
First triclosan-based macrocyclic inhibitors of InhA enzyme 63
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 60
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression 59
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 56
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 56
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 55
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 55
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 55
Distinct Effects of Moxifloxacin and Bedaquiline on Growing and 'Non-Culturable' Mycobacterium abscessus 52
Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis 49
P146 New weapons are necessary to fight Mycobacterium abscessus 47
The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis 46
Protocol to quantify bacterial burden in time-kill assays using colony-forming units and most probable number readouts for Mycobacterium tuberculosis. 45
Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium 44
Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential 44
Exploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors 44
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo 44
Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis 39
PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis 37
New Drugs and Novel Cellular Targets against Tuberculosis 36
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3 34
Whole cell screen based identification of spiropiperidines with potent antitubercular properties 33
Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes—Hydrazones with Antileishmanial and Antibacterial Activities 29
Totale 3.164
Categoria #
all - tutte 15.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202160 0 0 0 0 0 7 4 25 6 7 9 2
2021/2022141 5 1 1 0 2 2 5 14 8 5 14 84
2022/2023598 47 54 7 33 42 59 1 34 293 7 10 11
2023/2024300 50 52 8 16 18 54 12 28 5 15 26 16
2024/2025827 22 47 31 7 31 73 48 40 207 40 104 177
2025/2026963 127 125 208 228 258 17 0 0 0 0 0 0
Totale 3.164